Tocris Bioscience社 2016年2月新製品
New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
| Cat.No. | Product Name | Activity |
| 5751 | PF 3084014 hydrobromide | Potent γ-secretase inhibitor |
| 5702 | DiD perchlorate | Lipophilic fluorescent reagent; shown to stain HSCs |
| 5673 | GW 2580 | Selective cFMS kinase inhibitor |
| 5579 | Tilfrinib | Potent and selective breast tumor kinase (Brk) inhibitor |
| 5778 | 2-Phospho-L-ascorbic acid trisodium salt | Ascorbic acid derivative; maintains differentiation potential in bone marrow-derived MSCs |
| 5748 | DAPI | Fluorescent DNA stain |
| 5614 | AZD 2066 | mGlu5 antagonist; orally bioavailable and brain penetrant |
| 4645 | Z-VRPR-FMK trifluoroacetate salt | Irreversible MALT1 inhibitor |
| 3907 | 27-Hydroxycholesterol | LXR agonist; also ER partial agonist |
| 5728 | EXP 3174 | Potent and selective AT1 receptor antagonist |
| 5685 | MS049 oxalate salt | Potent and selective PRMT4 and PRMT6 inhibitor |
| 5599 | ML 18 | BRS-3 antagonist; also GRPR agonist |
| 5441 | 5-TAMRA SE | Fluorescent probe for DNA and RNA; also shown to stain telomeres |
| 5764 | Deferoxamine mesylate | Iron chelator; also hypoxia mimetic |
| 5763 | (R)-Citalopram oxalate | Enantiomer of escitalopram oxalate (Cat. No. 1427) |
| 5752 | PF 06260933 dihydrochloride | MAP4K4 (HGK) inhibitor; also inhibits MINK and TNIK |
| 5647 | MI 192 | Potent and selective HDAC2/3 inhibitor |
| 5645 | IPSU | OX2 receptor antagonist; orally bioavailable |
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。
